Multiple Sclerosis Trial, Recruiting (NCT04604041)

Multiple Sclerosis Trial, Recruiting NCT04604041 Sponsor: University of Split, School of Medicine Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT04604041 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been formally diagnosed with relapsing-remitting multiple sclerosis (a form of MS where symptoms come and go) based on recognised diagnostic guidelines (the McDonald criteria from 2005)
People whose level of physical disability, as measured by a standard MS rating scale called the EDSS, falls between 0 (no disability) and 3.5 (mild to moderate disability)

Who may not be able to join:

People who have metal objects inside their body, such as a pacemaker or metal dentures
People who are newly pregnant (confirmed by verbal confirmation)
People who have recently experienced a head injury
People who are unwilling to sign a consent form or follow the steps required by the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Maja Rogić Vidaković, MSc, PhD, University of Split, School of Medicine

Phone: 0038598508210

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04604041

Sponsor: University of Split, School of Medicine

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: 0038598508210

More information: https://clinicaltrials.gov/study/NCT04604041

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been formally diagnosed with relapsing-remitting multiple sclerosis (a form of MS where symptoms come and go) based on recognised diagnostic guidelines (the McDonald criteria from 2005)
People whose level of physical disability, as measured by a standard MS rating scale called the EDSS, falls between 0 (no disability) and 3.5 (mild to moderate disability)

Who may not be able to join:

People who have metal objects inside their body, such as a pacemaker or metal dentures
People who are newly pregnant (confirmed by verbal confirmation)
People who have recently experienced a head injury
People who are unwilling to sign a consent form or follow the steps required by the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Split, School of Medicine

Registry

ClinicalTrials.gov

Start date

23 November 2020

Est. completion

1 December 2024

Where this trial is recruiting

🇭🇷 Croatia

Primary endpoints

TMS assessment of resting motor threshold (RMT) change; TMS assessment of motor evoked potentials (MEP) changes from upper and lower extremity muscles; TMS assessment of cortical silent period (CSP) change; TMS assessment of short afferent latency inhibition (SAI) change; EMNG assessment of distal motor latency (DML) and sensory nerve action potential latency (SNAP) change; EMNG assessment of muscle action potential amplitude (CMAP) and sensory nerve action potential amplitude (SNAP) change; EMNG assessment of motor and sensory conduction velocity (CV) change; EMNG assessment of F-wave change;...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov